Free Trial

Integer (ITGR) Competitors

Integer logo
$107.03 -1.04 (-0.96%)
As of 12:49 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

ITGR vs. BDSX, ELV, BAX, MASI, GMED, TFX, ATEC, ATRC, IART, and OFIX

Should you be buying Integer stock or one of its competitors? The main competitors of Integer include Biodesix (BDSX), Elevance Health (ELV), Baxter International (BAX), Masimo (MASI), Globus Medical (GMED), Teleflex (TFX), Alphatec (ATEC), AtriCure (ATRC), Integra LifeSciences (IART), and Orthofix Medical (OFIX). These companies are all part of the "medical" sector.

Integer vs. Its Competitors

Biodesix (NASDAQ:BDSX) and Integer (NYSE:ITGR) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, media sentiment, institutional ownership, risk, dividends, valuation and earnings.

21.0% of Biodesix shares are owned by institutional investors. Comparatively, 99.3% of Integer shares are owned by institutional investors. 30.1% of Biodesix shares are owned by insiders. Comparatively, 2.2% of Integer shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Integer has higher revenue and earnings than Biodesix. Biodesix is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biodesix$71.32M0.94-$42.93M-$0.29-1.58
Integer$1.79B2.09$119.90M$2.2747.15

Biodesix currently has a consensus target price of $1.75, suggesting a potential upside of 282.93%. Integer has a consensus target price of $140.25, suggesting a potential upside of 31.04%. Given Biodesix's higher probable upside, analysts plainly believe Biodesix is more favorable than Integer.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Biodesix
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80
Integer
0 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
3.00

Integer has a net margin of 4.61% compared to Biodesix's net margin of -53.66%. Integer's return on equity of 12.27% beat Biodesix's return on equity.

Company Net Margins Return on Equity Return on Assets
Biodesix-53.66% -269.67% -43.94%
Integer 4.61%12.27%6.23%

Biodesix has a beta of 0.99, indicating that its stock price is 1% less volatile than the S&P 500. Comparatively, Integer has a beta of 1.02, indicating that its stock price is 2% more volatile than the S&P 500.

In the previous week, Integer had 6 more articles in the media than Biodesix. MarketBeat recorded 7 mentions for Integer and 1 mentions for Biodesix. Biodesix's average media sentiment score of 1.87 beat Integer's score of 1.59 indicating that Biodesix is being referred to more favorably in the media.

Company Overall Sentiment
Biodesix Very Positive
Integer Very Positive

Summary

Integer beats Biodesix on 14 of the 17 factors compared between the two stocks.

Get Integer News Delivered to You Automatically

Sign up to receive the latest news and ratings for ITGR and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ITGR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ITGR vs. The Competition

MetricIntegerMED INSTRUMENTS IndustryMedical SectorNYSE Exchange
Market Cap$3.75B$6.90B$5.75B$21.26B
Dividend YieldN/A1.30%3.95%3.53%
P/E Ratio47.1526.2830.7329.24
Price / Sales2.0955.97457.9453.45
Price / Cash12.1821.6137.7623.64
Price / Book2.206.9310.125.37
Net Income$119.90M$176.42M$3.27B$996.59M
7 Day Performance0.29%3.30%3.58%2.96%
1 Month Performance-0.92%-1.71%4.76%2.83%
1 Year Performance-16.09%9.69%45.41%12.71%

Integer Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ITGR
Integer
3.8586 of 5 stars
$107.03
-1.0%
$140.25
+31.0%
-15.0%$3.75B$1.79B47.1511,000Positive News
BDSX
Biodesix
3.5958 of 5 stars
$0.43
+7.2%
$1.75
+311.8%
-74.6%$58.11M$71.32M-1.47220Positive News
ELV
Elevance Health
4.8901 of 5 stars
$310.03
+0.1%
$413.81
+33.5%
-43.6%$69.71B$177.01B13.19104,200Positive News
BAX
Baxter International
4.7239 of 5 stars
$23.61
-2.4%
$30.11
+27.5%
-35.2%$12.42B$10.64B-78.7038,000
MASI
Masimo
4.3457 of 5 stars
$153.93
+0.0%
$193.60
+25.8%
+22.3%$8.36B$2.09B-18.075,600Positive News
Analyst Revision
GMED
Globus Medical
4.9488 of 5 stars
$60.27
-0.5%
$87.64
+45.4%
-14.2%$8.18B$2.52B23.185,300Positive News
TFX
Teleflex
4.7551 of 5 stars
$120.24
-0.4%
$141.57
+17.7%
-46.5%$5.33B$3.05B28.2914,100Positive News
ATEC
Alphatec
4.0092 of 5 stars
$15.86
+1.0%
$18.50
+16.6%
+156.0%$2.32B$611.56M-14.04700Positive News
ATRC
AtriCure
2.9495 of 5 stars
$35.62
+0.5%
$50.89
+42.9%
+45.7%$1.76B$465.31M-46.261,300Positive News
Insider Trade
IART
Integra LifeSciences
4.0794 of 5 stars
$14.05
-1.0%
$18.63
+32.6%
-27.5%$1.11B$1.61B-2.154,396
OFIX
Orthofix Medical
2.8947 of 5 stars
$14.51
+2.0%
$21.50
+48.2%
-15.2%$562M$799.49M-4.581,616News Coverage

Related Companies and Tools


This page (NYSE:ITGR) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners